GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » Days Sales Outstanding

Jacobson Pharma (HKSE:02633) Days Sales Outstanding : 39.07 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Jacobson Pharma Days Sales Outstanding?

Jacobson Pharma's average Accounts Receivable for the six months ended in Sep. 2024 was HK$173 Mil. Jacobson Pharma's Revenue for the six months ended in Sep. 2024 was HK$810 Mil. Hence, Jacobson Pharma's Days Sales Outstanding for the six months ended in Sep. 2024 was 39.07.

The historical rank and industry rank for Jacobson Pharma's Days Sales Outstanding or its related term are showing as below:

HKSE:02633' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.74   Med: 49.46   Max: 85.98
Current: 41.73

During the past 11 years, Jacobson Pharma's highest Days Sales Outstanding was 85.98. The lowest was 36.74. And the median was 49.46.

HKSE:02633's Days Sales Outstanding is ranked better than
79.75% of 968 companies
in the Drug Manufacturers industry
Industry Median: 71.165 vs HKSE:02633: 41.73

Jacobson Pharma's Days Sales Outstanding declined from Sep. 2023 (60.93) to Sep. 2024 (39.07).


Jacobson Pharma Days Sales Outstanding Historical Data

The historical data trend for Jacobson Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobson Pharma Days Sales Outstanding Chart

Jacobson Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.09 58.17 65.19 85.98 57.33

Jacobson Pharma Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.20 72.94 60.93 43.87 39.07

Competitive Comparison of Jacobson Pharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobson Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jacobson Pharma's Days Sales Outstanding falls into.



Jacobson Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jacobson Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (288.231 + 172.834) / 2 ) / 1467.798*365
=230.5325 / 1467.798*365
=57.33

Jacobson Pharma's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding (Q: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (172.834 + 174.017) / 2 ) / 810.002*365 / 2
=173.4255 / 810.002*365 / 2
=39.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jacobson Pharma  (HKSE:02633) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Jacobson Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jacobson Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobson Pharma Business Description

Traded in Other Exchanges
N/A
Address
388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG
Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.
Executives
Sum Kwong Yip, Derek 2305 Beneficiary of a trust
Lau Wing Hung
Kingshill Development Group Inc
Kingshill Development Limited
Ubs Trustees (b.v.i.) Limited
Queenshill Development Limited
Longjin Investments Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si

Jacobson Pharma Headlines

No Headlines